Abstract
As the vast majority of the active principles of pharmaceuticals are organic compounds, inorganic analysis* has usually played a minor role in all the analyses performed in the pharmaceutical industry. But during the last few years its importance has steadily grown. The classical task of inorganic analysis was the simple analysis of residues, usually performed by relatively unselective methods. Examples are determination of sulphate ash, or “heavy metal” analysis by the method of sulphide precipitation. Methods such as complexometric titration played a certain role, e.g., in the case of assay determination of inorganic active principles, such as calcium formulations. The rise of the importance of inorganic analysis has various reasons. First of all come certainly safety considerations. These led to the pharmaceutical industry to use analyses which are more specific, selective, and sensitive than the methods prescribed by authorities. Nowadays other factors than safety considerations play an important role, as traces of metals may have an effect on the mechanism of the action of certain compounds (e.g. proteins which are prone to metal — protein interaction), or metals which strongly influence the production process (e.g. catalysis). The case of protein based innovative pharmaceuticals is also a good example to illustrate the change in inorganic analysis. Being up to now a macro trace analysis the amount of sample available for analysis was never an aspect to be considered. The restricted amount of synthesized proteins (milligrams only) necessitate micro scale trace determination.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
W. Simon, Proceedings of the Electro Finn Analysis, Turku 1988.
N. Gopalsamy, V. Pfund, P. Rach and J.B. Reust, Analusis, 16 (1988) 55.
P. Schramel, S. Hasse and G. Knapp, Fresenius’ Z. Anal. Chem., 326 (1987) 142.
R. Neeb, et al., Analusis, submitted for publication.
D. Frahne, J.V. Geil, K. Geng and U. Schrader, Metrohm Monografie, Metrohm AG, Januar 1982, Herisau (CH).
P.M. Bersier, personal communication.
R. Maurer and J.B. Reust, in preparation.
E. Grollimund and J.B. Reust, in: “Electrochemistry, Sensors and Analysis”, M.R. Smyth and J.G. Vos (Eds), Anal. Chem. Symposia Series, 25 Elsevier, Amsterdam, 1987, 411.
Mitsubishi application manual, Mitsubishi Chemical Industries Ltd., Tokyo (J), 1988.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Reust, J.B. (1990). Applications and Potentiality of Electroanalytical Methods for Inorganic Trace Analysis in the Pharmaceutical Industry. In: Ivaska, A., Lewenstam, A., Sara, R. (eds) Contemporary Electroanalytical Chemistry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3704-9_41
Download citation
DOI: https://doi.org/10.1007/978-1-4899-3704-9_41
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-3706-3
Online ISBN: 978-1-4899-3704-9
eBook Packages: Springer Book Archive